Use of continuous infusion of pralidoxime for treatment of organophosphate poisoning in children.
Farrar
H C
HC
Department of Pediatrics, University of Arkansas for Medical Science, Little Rock.
Wells
T G
TG
Kearns
G L
GL
D000293:Adolescent; D000931:Antidotes / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002801:Cholinesterase Reactivators / Q000008:administration & dosage / Q000627:therapeutic use*; D002802:Cholinesterases / Q000097:blood; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D007306:Insecticides / Q000506:poisoning*; D008297:Male; D009943:Organophosphorus Compounds; D011220:Pralidoxime Compounds / Q000008:administration & dosage / Q000627:therapeutic use*
D000931:Antidotes; D002801:Cholinesterase Reactivators; D007306:Insecticides; D009943:Organophosphorus Compounds; D011220:Pralidoxime Compounds; D002802:Cholinesterases; C028797:pralidoxime